Axunio Ltd

Axunio Ltd is a UK-based pharmaceutical company headquartered in Reading, England, and the UK subsidiary of Axunio Pharma GmbH (Germany). Formerly operating as Leith Healthcare Limited, the company rebranded as Axunio Ltd in July 2025 following its acquisition by Axunio Pharma GmbH. Specialising in innovative healthcare brands that address unmet patient needs, Axunio Ltd holds the UK Marketing Authorisation for Axhidrox (glycopyrronium bromide cream), a topical prescription treatment for severe primary axillary hyperhidrosis in adults, which received UK marketing authorisation in June 2025.